Homology Medicines announced that it received notification from Nasdaq indicating that, for the last thirty consecutive business days, the bid price for the company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Global Select Market.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on FIXX: